Equitec Proprietary Markets »

Avadel Pharmaceuticals shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 511k 21.55

More positions owned by Equitec Proprietary Markets

Netflix Call Option (NFLX)
Cidara Therapeutics Com New Call Option (CDTX)
Hologic (HOLX)
Avadel Pharmaceuticals Com Shs Call Option (AVDL)
Paramount Skydance Corp Com Cl B (PSKY)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts Call Option (EA)
Boeing Company Put Option (BA)
Brighthouse Finl (BHF)
Western Midstream Partners L Com Unit Lp Int (WES)
Kayne Anderson Bdc Com Shs (KBDC)
Siriusxm Holdings Common Stock (SIRI)
Wolfspeed Common Stock Put Option (WOLF)
Dynavax Technologies Corp Com New (DVAX)
Strategy Cl A New Call Option (MSTR)

View all positions for Equitec Proprietary Markets

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Jeffrey L. Gendell
Vanguard Group
Vivo Capital
State Street Corporation
Geode Capital Management
Highbridge Capital Management
Susquehanna International
Wealth Effects
Citadel Advisors
Kennedy Capital Management
Krensavage Asset Management
Northern Trust
Charles Schwab Investment Management

View all funds holding Avadel Pharmaceuticals